Researchers find the more MRI scanners in an area, the more patients get a controversial treatment for lower back pain.
A Massachusetts start-up hopes its warning device could help save people from one of the leading causes of death.
Gap between best and worst widens, according to HealthGrades' latest report.
Spared the worst of the recession and blessed with increasing affluence, middle-income countries like China and Russia are expected to hold 37 percent of the diagnostic imaging market by 2013, according to analysts.
Over 30,000 radiological exams are up for review in the Canadian province of New Brunswick after colleagues suspect a physician of misinterpreting results.
Explore the human body with a new iPhone program.
Thanks to electron's quantum quirk, electron microscopes could one day view cells without killing them.
The HHS Inspector General aims to sniff out waste, abuse in emergency X-ray use and imaging reimbursements in response to high cost of imaging services. But are concerns misdirected? DOTmed spoke to ACR.
Consumer goods behemoth acquires the maker of pain-management drug pumps.
Next Generation Health Care Summit brings execs from GE, Verizon and Ochsner to discuss industry challenges.
Patients at Los Angeles hospital have been overexposed by brain scan.
Preliminary results "imminent" from proof-of-concept study using Profound Medical's MRI-guided ultrasound device to heat-treat prostate cancer.
Surprising preliminary results so far suggest no harm is done.
The recently FDA-cleared gel is designed to prevent kidney stones from escaping the ureter during treatments.
MetroHealth Medical Center in Cleveland, Ohio has been the test site for what Philips Healthcare claims is one of the first of its kind: an MRI conversion.
Nuance's critical test result alert software now part of Agfa's health IT platform.
Health care providers should wear N95 masks--amidst fears of a global H1N1 outbreak, new warnings about non-invasive ventilation.
Research presented at British conference this week could lead to anti-cancer breakthroughs -- and a drug's already in the pipeline.
Light-detecting tubes could be a thing of the past as a technology behind PET goes from analog to digital.
SonoSite's NanoMaxx system, based on technology built for the battlefield, gets the FDA OK.
The breakthrough single-port surgical device gets cash needed for commercialization.
Magnetic interference from portable headphones can cause potentially life-threatening problems with implanted pacemakers, defibrillators.
Proposed changes to Medicare could slash reimbursements by at least 26 percent, according to market consulting firm.
Modest improvements seen, but not "quality panacea."
Researcher who helped develop ovarian cancer test returns from Roche.
Brain cancer patients lose some cognitive function after whole-brain radiation treatments, according to a study published online and ahead-of-publication in The Lancet.
Hackers might have gained access to the confidential medical history of 160,000 women in the University of North Carolina-Chapel Hill's mammography database.
Screws and other implants made of this magnesium-based material might not need to be removed in follow-up surgeries.
Technique using mass spectrometry and electrosurgery could help surgeons know when they've fully removed a tumor in under one second.
Different rates of uptake of two tracers can help doctors determine the aggressiveness of uterine cancers.
Doctors at a VA hospital in Texas find that even with EHR in place, critical alerts get missed.
Sequenom sacks CEO, vice president of R&D following revelations that results from its highly anticipated test for Down syndrome were mishandled.
Technology using ultra-fine slices of frozen specimens lets researchers microscopically examine an entire mouse -- right down to a single cell.
One of the largest studies ever conducted on the aftereffects of radiation treatment for prostate cancer aims to ease urologists' fears.
Thomson Reuters names Seiji Ogawa, the discoverer of functional MRIs, as a contender for the Nobel Prize in Physiology or Medicine.
Covidien adds brain-monitoring technology to its portfolio with Aspect.
First ever master's degree program for nuclear medicine technologists begins this fall.
St. Jude's tool to measure fractional flow reserve could help avoid unneeded stents.
Former Senate adviser and Medtronic lobbyist expected to come on board in October.
Relief could be on its way for women who suffer from unusually severe menstrual pains, if findings to be presented this fall at the annual meeting of the American Association of Pharmaceutical Scientists hold true.
Bedside test trumps technology in predicting certain kinds of strokes.
A massive study in Europe might shed light on why some patients are highly vulnerable to radiation.
A heat-activated drug and a new temperature-raising ultrasound device might offer precisely targeted cancer treatment.
Forget fasting glucose levels: a new way to identify those at risk of developing diabetes could be imaging for fat buildup in the pancreas.
Two commonly used contrast agents only trigger adverse reactions in about one out of 1,000 cases.
Ability to learn among those in vegetative states predicts likelihood of recovery, suggesting some retention of awareness.
Deal to manufacture fast new imaging modality might be signed as early as the end of this year.
Test could improve survival rates by identifying which women need to see a specialist for their surgeries.
Scientists in Israel believe new treatments could eventually turn cancer into a chronically manageable disease. The tumor dormancy model may transform cancer care.
New study shows CT scans provide a SPECT-comparable picture of heart function while also detecting arterial narrowing.
